Allcyte Information

View Top Employees from Allcyte

Allcyte is proud to now be part of Exscientia, a global pharmatech company using patient-first artificial intelligence (AI) to discover better drugs, faster. Our mission is to encode, automate and transform every stage of the drug design and development process, by combining the latest AI techniques with experimental innovation, to enable the design of patient centric drug candidates with an improved probability of success. Our validated platform has delivered the first three AI-designed drugs to enter clinical trials and is the first AI system proven to improve clinical outcomes in oncology. We’ve significantly accelerated pre-clinical drug discovery, with 10x productivity improvement in delivering a drug candidate compared with industry standards. By actively applying AI to precision engineer medicines more rapidly and efficiently, we allow the best ideas of science to rapidly become the best medicines for patients.

Website	https://www.exscientia.ai/
Revenue	$8 million
Employees	5 (2 on RocketReach)
Founded	2017
Address	5 Campus-vienna-biocenter, Kien, Upper Austria 4841, AT
Phone	+43 1 3982020
Technologies	JavaScript , HTML , PHP +29 more (view full list)
Industry	Biotechnology, Business Services General, Business Services, Science and Engineering, Pharmaceutical, Health Care
Keywords	Ai Drug Discovery, Biotechnology Ai, Machine Learning Pharma, Computational Drug Design, Data Driven Drug Discovery, Accelerated Drug Development, Precision Medicine Ai, Innovative Drug Development
Competitors	Thermo Fisher Scientific, Bristol Myers Squibb, EQT Partners/EQT AB, Schrödinger, Recursion Pharmaceuticals, Insilico Medicine, Atomwise, BenevolentAI, CYCLICA, ZebiAI +35 more (view full list)
SIC	SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies